NCT05987098View on ClinicalTrials.gov

BBPA PET/CT in Patients With Malignant Tumors

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

June 1, 2024

Study Completion Date

September 1, 2024

Conditions
Malignant Tumors
Interventions
DIAGNOSTIC_TEST

BBPA PET examination

A single dose of 0.10 mCi/kg BBPA will be intravenously injected and PET examination will carry out 30 minutes later.

Trial Locations (1)

10005

RECRUITING

Wenbin Ma, Beijing

All Listed Sponsors
collaborator

Peking University

OTHER

collaborator

Peking University Cancer Hospital & Institute

OTHER

lead

Peking Union Medical College Hospital

OTHER